MeSH tree: C12.900.820.535
Today, small kidney tumors are most often treated with a minor operation in which all or part of the kidney is removed. However, in many cases, these small tumors can be treated with targeted cryotherapy, which destroys the ...
Mar 5, 2026
0
0
The Y chromosome is among the smallest in the human body and carries the fewest genes. Researchers are paying renewed attention to its role in cancer—specifically, what happens when it vanishes.
Mar 2, 2026
0
0
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when treated with an oral combination ...
Mar 2, 2026
0
0
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way that can be compared between ...
Feb 9, 2026
0
0
This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's putting that claim to the test. After attracting global attention from researchers and billions ...
Feb 7, 2026
0
0
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in the Nature Medicine journal. The first study shows that the toxic side effects of drugs to treat ...
Jan 28, 2026
0
66
Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These antibodies activate the immune system and enable T cells to detect and destroy tumor cells.
Jan 15, 2026
0
0
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the potential to overcome treatment ...
Jan 13, 2026
0
18
Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine.
Dec 18, 2025
0
0
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.
Nov 3, 2025
0
2
